Virgin Islands). During 2011â2015, the annual number and rate of diagnoses of HIV infection in the United States decre
Volume 28
Diagnoses of HIV Infection in the United States and Dependent Areas, 2016
The HIV Surveillance Report is published annually by the Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC), U.S. Department of Health and Human Services, Atlanta, Georgia. Data are presented for diagnoses of HIV infection reported to CDC through June 2017. The HIV Surveillance Report is not copyrighted and may be used and reproduced without permission. Citation of the source is, however, appreciated. Suggested citation Centers for Disease Control and Prevention. HIV Surveillance Report, 2016; vol. 28. http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html. Published November 2017. Accessed [date]. On the Web: http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html Confidential information, referrals, and educational material on HIV infection CDC-INFO 1-800-232-4636 (in English, en Español) 1-888-232-6348 (TTY) http://wwwn.cdc.gov/dcs/ContactUs/Form Acknowledgments Publication of this report would not have been possible without the contributions of the state and territorial health departments and the HIV surveillance programs that provided surveillance data to CDC. This report was prepared by the following CDC staff and contractors: Kristen Hess, Anna Satcher Johnson, Xiaohong Hu, Jianmin Li, Baohua Wu, Chenchen Yu, Hong Zhu, Chan Jin, Mi Chen, John Gerstle, Marie Morgan, Michael Friend, Azfar Siddiqi, Angela Hernandez, the HIV Incidence and Case Surveillance Branch, and the Data Management Team of the Quantitative Sciences and Data Management Branch.
HIV Surveillance Report
2
Vol. 28
Contents Contents
Commentary Technical Notes Tables Section 1 Diagnoses of HIV Infection and Diagnoses of Infection Classified as Stage 3 (AIDS) 1a Diagnoses of HIV infection, by year of diagnosis and selected characteristics, 2011–2016—United States 1b Diagnoses of HIV infection, by year of diagnosis and selected characteristics, 2011–2016—United States and 6 dependent areas 2a Stage 3 (AIDS), by year of diagnosis and selected characteristics, 2011–2016 and cumulative—United States 2b Stage 3 (AIDS), by year of diagnosis and selected characteristics, 2011–2016 and cumulative—United States and 6 dependent areas 3a Diagnoses of HIV infection, by race/ethnicity and selected characteristics, 2016—United States 3b Diagnoses of HIV infection, by race/ethnicity and selected characteristics, 2016—United States and 6 dependent areas 4a Stage 3 (AIDS), by race/ethnicity and selected characteristics, 2016—United States 4b Stage 3 (AIDS), by race/ethnicity and selected characteristics, 2016—United States and 6 dependent areas 5a Diagnoses of HIV infection attributed to male-to-male sexual contact and male-to-male sexual contact and injection drug use, by selected characteristics, 2011–2016—United States 5b Diagnoses of HIV infection attributed to male-to-male sexual contact and male-to-male sexual contact and injection drug use, by selected characteristics, 2011–2016—United States and 6 dependent areas 6a Diagnoses of HIV infection attributed to injection drug use, by selected characteristics, 2011–2016— United States 6b Diagnoses of HIV infection attributed to injection drug use, by selected characteristics, 2011–2016—United States and 6 dependent areas 7a Diagnoses of HIV infection attributed to heterosexual contact, by selected characteristics, 2011–2016— United States 7b Diagnoses of HIV infection attributed to heterosexual contact, by selected characteristics, 2011–2016—United States and 6 dependent areas 8a Stage 3 (AIDS) attributed to male-to-male sexual contact and male-to-male sexual contact and injection drug use, by selected characteristics, 2011–2016—United States 8b Stage 3 (AIDS) attributed to male-to-male sexual contact and male-to-male sexual contact and injection drug use, by selected characteristics, 2011–2016—United States and 6 dependent areas 9a Stage 3 (AIDS) attributed to injection drug use, by selected characteristics, 2011–2016—United States 9b Stage 3 (AIDS) attributed to injection drug use, by selected characteristics, 2011–2016—United States and 6 dependent areas 10a Stage 3 (AIDS) attributed to heterosexual contact, by selected characteristics, 2011–2016—United States 10b Stage 3 (AIDS) attributed to heterosexual contact, by selected characteristics, 2011–2016—United States and 6 dependent areas 11a Diagnoses of HIV infection among children aged
